Fauser Mareike, Payonk Jan Philipp, Weber Hanna, Statz Meike, Winter Christine, Hadar Ravit, Appali Revathi, van Rienen Ursula, Brandt Moritz D, Storch Alexander
Department of Neurology, University of Rostock, Rostock, Germany.
Institute of General Electrical Engineering, University of Rostock, Rostock, Germany.
Front Cell Neurosci. 2024 Apr 30;18:1396780. doi: 10.3389/fncel.2024.1396780. eCollection 2024.
INTRODUCTION: Deep brain stimulation (DBS) is a highly effective treatment option in Parkinson's disease. However, the underlying mechanisms of action, particularly effects on neuronal plasticity, remain enigmatic. Adult neurogenesis in the subventricular zone-olfactory bulb (SVZ-OB) axis and in the dentate gyrus (DG) has been linked to various non-motor symptoms in PD, e.g., memory deficits and olfactory dysfunction. Since DBS affects several of these non-motor symptoms, we analyzed the effects of DBS in the subthalamic nucleus (STN) and the entopeduncular nucleus (EPN) on neurogenesis in 6-hydroxydopamine (6-OHDA)-lesioned hemiparkinsonian rats. METHODS: In our study, we applied five weeks of continuous bilateral STN-DBS or EPN-DBS in 6-OHDA-lesioned rats with stable dopaminergic deficits compared to 6-OHDA-lesioned rats with corresponding sham stimulation. We injected two thymidine analogs to quantify newborn neurons early after DBS onset and three weeks later. Immunohistochemistry identified newborn cells co-labeled with NeuN, TH and GABA within the OB and DG. As a putative mechanism, we simulated the electric field distribution depending on the stimulation site to analyze direct electric effects on neural stem cell proliferation. RESULTS: STN-DBS persistently increased the number of newborn dopaminergic and GABAergic neurons in the OB but not in the DG, while EPN-DBS does not impact neurogenesis. These effects do not seem to be mediated via direct electric stimulation of neural stem/progenitor cells within the neurogenic niches. DISCUSSION: Our data support target-specific effects of STN-DBS on adult neurogenesis, a putative modulator of non-motor symptoms in Parkinson's disease.
Brain Struct Funct. 2015-11
Neuroscience. 2014-2-14
NPJ Parkinsons Dis. 2024-11-8
Cereb Cortex. 2023-11-4
Mov Disord Clin Pract. 2020-12-21